Software - Application
Compare Stocks
5 / 10Stock Comparison
IFBD vs AIXI vs CLPS vs NICE vs FIVN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Information Technology Services
Software - Application
Software - Infrastructure
IFBD vs AIXI vs CLPS vs NICE vs FIVN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Information Technology Services | Software - Application | Software - Infrastructure |
| Market Cap | $5M | $8M | $25M | $5.78B | $1.70B |
| Revenue (TTM) | $5M | $115M | $299M | $2.95B | $1.17B |
| Net Income (TTM) | $-2M | $-53M | $-4M | $612M | $57M |
| Gross Margin | 39.3% | 64.3% | 22.8% | 66.4% | 55.1% |
| Operating Margin | -99.4% | -44.2% | -1.4% | 21.9% | 4.7% |
| Forward P/E | — | — | — | 8.7x | 7.0x |
| Total Debt | $505K | $46M | $34M | $164M | $847M |
| Cash & Equiv. | $5M | $847K | $28M | $379M | $232M |
IFBD vs AIXI vs CLPS vs NICE vs FIVN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 23 | May 26 | Return |
|---|---|---|---|
| Infobird Co., Ltd (IFBD) | 100 | 0.2 | -99.8% |
| Xiao-I Corporation (AIXI) | 100 | 1.2 | -98.8% |
| CLPS Incorporation (CLPS) | 100 | 80.9 | -19.1% |
| NICE Ltd. (NICE) | 100 | 41.8 | -58.2% |
| Five9, Inc. (FIVN) | 100 | 30.7 | -69.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IFBD vs AIXI vs CLPS vs NICE vs FIVN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IFBD ranks third and is worth considering specifically for growth exposure.
- Rev growth 413.5%, EPS growth 84.0%, 3Y rev CAGR -47.0%
- 413.5% revenue growth vs NICE's 7.7%
Among these 5 stocks, AIXI doesn't own a clear edge in any measured category.
CLPS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 0.27, yield 14.6%
- Lower volatility, beta 0.27, Low D/E 58.8%, current ratio 1.58x
- Beta 0.27, yield 14.6%, current ratio 1.58x
- Beta 0.27 vs FIVN's 1.79, lower leverage
NICE is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 50.7% 10Y total return vs FIVN's 125.4%
- 20.8% margin vs AIXI's -45.9%
- 11.8% ROA vs AIXI's -65.3%, ROIC 13.2% vs -34.4%
FIVN is the clearest fit if your priority is value.
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 413.5% revenue growth vs NICE's 7.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.8% margin vs AIXI's -45.9% | |
| Stability / Safety | Beta 0.27 vs FIVN's 1.79, lower leverage | |
| Dividends | 14.6% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -5.4% vs AIXI's -79.2% | |
| Efficiency (ROA) | 11.8% ROA vs AIXI's -65.3%, ROIC 13.2% vs -34.4% |
IFBD vs AIXI vs CLPS vs NICE vs FIVN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IFBD vs AIXI vs CLPS vs NICE vs FIVN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 3 of 6 categories
CLPS leads 2 • IFBD leads 0 • AIXI leads 0 • FIVN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 570.7x IFBD's $5M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to AIXI's -45.9%. On growth, IFBD holds the edge at +171.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5M | $115M | $299M | $2.9B | $1.2B |
| EBITDAEarnings before interest/tax | -$5M | -$49M | -$1M | $845M | $140M |
| Net IncomeAfter-tax profit | -$2M | -$53M | -$4M | $612M | $57M |
| Free Cash FlowCash after capex | -$4M | -$2M | $0 | $665M | $206M |
| Gross MarginGross profit ÷ Revenue | +39.3% | +64.3% | +22.8% | +66.4% | +55.1% |
| Operating MarginEBIT ÷ Revenue | -99.4% | -44.2% | -1.4% | +21.9% | +4.7% |
| Net MarginNet income ÷ Revenue | -32.7% | -45.9% | -1.3% | +20.8% | +4.9% |
| FCF MarginFCF ÷ Revenue | -70.6% | -2.0% | -2.3% | +22.6% | +17.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +171.2% | -64.9% | +15.3% | +9.0% | +9.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.7% | -29.9% | +75.8% | +56.5% | +20.0% |
Valuation Metrics
NICE leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 80% valuation discount to FIVN's 48.3x P/E. On an enterprise value basis, NICE's 6.6x EV/EBITDA is more attractive than FIVN's 16.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5M | $8M | $25M | $5.8B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $994,534 | $53M | $31M | $5.6B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | -0.90x | -0.45x | -3.48x | 9.89x | 48.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 8.74x | 6.96x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.37x | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 6.59x | 16.84x |
| Price / SalesMarket cap ÷ Revenue | 3.60x | 0.11x | 0.15x | 1.96x | 1.48x |
| Price / BookPrice ÷ Book value/share | 0.03x | — | 0.43x | 1.56x | 2.46x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 8.22x | 8.45x |
Profitability & Efficiency
NICE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-6 for CLPS. IFBD carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to FIVN's 1.08x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs CLPS's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.5% | — | -6.1% | +16.4% | +7.4% |
| ROA (TTM)Return on assets | -2.3% | -65.3% | -3.2% | +11.8% | +3.2% |
| ROICReturn on invested capital | -2.2% | -34.4% | -7.9% | +13.2% | +1.7% |
| ROCEReturn on capital employed | -2.7% | -3.4% | -9.8% | +16.1% | +2.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 2 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.01x | — | 0.59x | 0.04x | 1.08x |
| Net DebtTotal debt minus cash | -$4M | $45M | $6M | -$216M | $615M |
| Cash & Equiv.Liquid assets | $5M | $846,593 | $28M | $379M | $232M |
| Total DebtShort + long-term debt | $505,225 | $46M | $34M | $164M | $847M |
| Interest CoverageEBIT ÷ Interest expense | -1.95x | -14.13x | — | — | 7.94x |
Total Returns (Dividends Reinvested)
CLPS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NICE five years ago would be worth $4,090 today (with dividends reinvested), compared to $1 for IFBD. Over the past 12 months, CLPS leads with a -5.4% total return vs AIXI's -79.2%. The 3-year compound annual growth rate (CAGR) favors CLPS at 0.2% vs IFBD's -84.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.9% | +68.1% | -10.3% | -14.6% | +18.0% |
| 1-Year ReturnPast 12 months | -15.2% | -79.2% | -5.4% | -40.4% | -11.9% |
| 3-Year ReturnCumulative with dividends | -99.6% | -98.6% | +0.5% | -49.3% | -61.4% |
| 5-Year ReturnCumulative with dividends | -100.0% | -98.6% | -69.3% | -59.1% | -87.0% |
| 10-Year ReturnCumulative with dividends | -100.0% | -98.6% | -78.5% | +50.7% | +125.4% |
| CAGR (3Y)Annualised 3-year return | -84.3% | -75.9% | +0.2% | -20.2% | -27.2% |
Risk & Volatility
Evenly matched — IFBD and FIVN each lead in 1 of 2 comparable metrics.
Risk & Volatility
IFBD is the less volatile stock with a -0.09 beta — it tends to amplify market swings less than FIVN's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FIVN currently trades 73.1% from its 52-week high vs AIXI's 18.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.09x | 0.94x | 0.27x | 0.72x | 1.79x |
| 52-Week HighHighest price in past year | $1.69 | $4.02 | $1.88 | $180.61 | $30.38 |
| 52-Week LowLowest price in past year | $0.66 | $0.08 | $0.80 | $94.89 | $13.29 |
| % of 52W HighCurrent price vs 52-week peak | +56.2% | +18.0% | +48.2% | +53.0% | +73.1% |
| RSI (14)Momentum oscillator 0–100 | 46.7 | 49.3 | 49.8 | 40.9 | 68.1 |
| Avg Volume (50D)Average daily shares traded | 3K | 60.6M | 15K | 631K | 2.8M |
Analyst Outlook
CLPS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NICE as "Buy", FIVN as "Buy". Consensus price targets imply 57.8% upside for NICE (target: $151) vs 27.9% for FIVN (target: $28). CLPS is the only dividend payer here at 14.60% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | — | $150.88 | $28.40 |
| # AnalystsCovering analysts | — | — | — | 23 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | — | +14.6% | — | — |
| Dividend StreakConsecutive years of raises | — | — | 3 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | $0.13 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +8.5% | +2.9% |
NICE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CLPS leads in 2 (Total Returns, Analyst Outlook). 1 tied.
IFBD vs AIXI vs CLPS vs NICE vs FIVN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IFBD or AIXI or CLPS or NICE or FIVN a better buy right now?
For growth investors, Infobird Co.
, Ltd (IFBD) is the stronger pick with 413. 5% revenue growth year-over-year, versus 7. 7% for NICE Ltd. (NICE). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IFBD or AIXI or CLPS or NICE or FIVN?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Five9, Inc. at 48. 3x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IFBD or AIXI or CLPS or NICE or FIVN?
Over the past 5 years, NICE Ltd.
(NICE) delivered a total return of -59. 1%, compared to -100. 0% for Infobird Co. , Ltd (IFBD). Over 10 years, the gap is even starker: FIVN returned +125. 4% versus IFBD's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IFBD or AIXI or CLPS or NICE or FIVN?
By beta (market sensitivity over 5 years), Infobird Co.
, Ltd (IFBD) is the lower-risk stock at -0. 09β versus Five9, Inc. 's 1. 79β — meaning FIVN is approximately -2158% more volatile than IFBD relative to the S&P 500. On balance sheet safety, Infobird Co. , Ltd (IFBD) carries a lower debt/equity ratio of 1% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IFBD or AIXI or CLPS or NICE or FIVN?
By revenue growth (latest reported year), Infobird Co.
, Ltd (IFBD) is pulling ahead at 413. 5% versus 7. 7% for NICE Ltd. (NICE). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to -181. 4% for CLPS Incorporation. Over a 3-year CAGR, AIXI leads at 29. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IFBD or AIXI or CLPS or NICE or FIVN?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -146. 0% for Infobird Co. , Ltd — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -120. 6% for IFBD. At the gross margin level — before operating expenses — AIXI leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IFBD or AIXI or CLPS or NICE or FIVN more undervalued right now?
On forward earnings alone, Five9, Inc.
(FIVN) trades at 7. 0x forward P/E versus 8. 7x for NICE Ltd. — 1. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.
08Which pays a better dividend — IFBD or AIXI or CLPS or NICE or FIVN?
In this comparison, CLPS (14.
6% yield) pays a dividend. IFBD, AIXI, NICE, FIVN do not pay a meaningful dividend and should not be held primarily for income.
09Is IFBD or AIXI or CLPS or NICE or FIVN better for a retirement portfolio?
For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
27), 14. 6% yield). Five9, Inc. (FIVN) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -78. 5%, FIVN: +125. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IFBD and AIXI and CLPS and NICE and FIVN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IFBD is a small-cap high-growth stock; AIXI is a small-cap high-growth stock; CLPS is a small-cap high-growth stock; NICE is a small-cap deep-value stock; FIVN is a small-cap quality compounder stock. CLPS pays a dividend while IFBD, AIXI, NICE, FIVN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.